Wednesday, 11 December 2013

Oxytocin 'Normalizes' Social Deficits in Kids With Autism



A single dose of the hormone oxytocin administered via nasal spray enhances brain activity in key regions, temporarily improving social information processing in children with autism spectrum disorder (ASD).

Tuesday, 10 December 2013

Smoking Pot May Double Risk for Stillbirth
Cannabis (tetrahydrocannabinolic acid), smoking, illicit drug use, and secondhand smoke exposure are linked to increased risk for stillbirth twofold. Secondhand smoke alone also almost doubled the odds of stillbirth.

Monday, 9 December 2013

FDA and EMEA approve of Game Changer Sofosbuvir 

   
 Sofosbuvir is a first-in-class polymerase inhibitor that allows for   all-oral, interferon-free therapy for some patients with hepatitis  C and reduced treatment time for most.

The US Food and Drug Administration (FDA) has approved the first-in-kind nuceotide analog inhibitor sofosbuvir (Sovaldi, Gilead Sciences, Inc) for the treatment of adults with chronic hepatitis C virus (HCV) infection, a widely anticipated move that is expected to dramatically improve outcomes for many patients.

The European Medicines Agency's Committee for Medicinal Products for Human use (CHMP) has recommended granting a marketing authorisation for Sovaldi (sofosbuvir), for use 'in combination with other medicinal products for the treatment of chronic (long-term) hepatitis C in adults'.

Friday, 6 December 2013

Clobazam (Onfi) Can Cause Serious Skin Reactions, FDA Warns 



The antiseizure drug clobazam (Onfi, Lundbeck) can trigger rare but potentially fatal skin reactions, the US Food and Drug Administration (FDA) announced today.
For clobazam, the skin reactions to watch for are Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Patients taking clobazam can experience these disorders at any time, but the risk goes up during the first 8 weeks of treatment or when treatment resumes after it was stopped. All the cases of these 2 adverse events identified by the FDA landed patients in the hospital, with 1 patient going blind and another dying.



Thursday, 5 December 2013

Oral Cancer Screening

Squamous cell carcinoma accounts for 90% of all cases of oral cavity and pharyngeal cancer. More than half of persons with oral and pharyngeal cancer have regional or distant metastases when they are first diagnosed. The USPSTF therefore stated that screening for oral cancer may be helpful if potentially malignant disorders can be identified earlier and treated successfully.



ORAL CANCER SCREENING METHODS

Thursday, 28 November 2013

Tuesday, 26 November 2013

ACRI - PGDCR Batch 17 Presentation

Amresh of batch 17, presented the topic of orphan drugs. This presentation was very instructive and covered all the sockets of regulations and incentives in different countries for orphan drugs.
acriindia.com